Process Validation in Dermatology: Assessing Wound Creation Methods and Treatment Efficacy - Trial NCT06379516
Access comprehensive clinical trial information for NCT06379516 through Pure Global AI's free database. This phase not specified trial is sponsored by NovoBliss Research Pvt Ltd and is currently Completed. The study focuses on Validation of the Process of Wound Creation and Evaluation. Target enrollment is 5 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Moisturising Cream (5%)
Interventional
other
Sponsor & Location
NovoBliss Research Pvt Ltd
Timeline & Enrollment
N/A
Jan 17, 2024
Feb 16, 2024
Primary Outcome
Trans Epidermal Water Loss (TEWL),Skin hydration,Skin surface topography
Summary
The primary objective of this study is to validate controlled methods of wound, including
 1%w/v SLS, 3%w/v SLS, and 24-24 times tape stripping, on the forearms of subjects.
 
 The study aims to standardize the procedures for creating wounds and systematically evaluate
 the effects of these methods on various skin parameters.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06379516
Non-Device Trial